Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Arbutus Biopharma Corp (ABUS)

Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Arbutus: Q1 Earnings Snapshot AP - Thu May 2, 6:44AM CDT

Arbutus: Q1 Earnings Snapshot

ABUS : 3.79 (+2.71%)
Arbutus: Q3 Earnings Snapshot AP - Tue Nov 7, 2023

Arbutus: Q3 Earnings Snapshot

ABUS : 3.79 (+2.71%)
Author
3 Stocks to Buy For the COVID Resurgence MarketBeat - Wed Sep 6, 2023

The cold and flu season is upon us, but COVID-19 cases and hospitalizations have also increased recently. The Centers for Disease Control (CDC) will be voting

MRNA : 121.72 (+0.48%)
NVAX : 14.62 (+5.56%)
PFE : 29.58 (-1.30%)
ALNY : 236.35 (-0.62%)
ABUS : 3.79 (+2.71%)
BNTX : 84.43 (-1.21%)
CVAC : 3.73 (+1.63%)
LGF-A : N/A (N/A)
Arbutus: Q2 Earnings Snapshot AP - Thu Aug 3, 2023

Arbutus: Q2 Earnings Snapshot

ABUS : 3.79 (+2.71%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arbutus Biopharma Corporation - ABUS PR Newswire - Wed May 10, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arbutus Biopharma Corporation ("Arbutus" or the "Company") (NASDAQ: ABUS). Such...

ABUS : 3.79 (+2.71%)
Arbutus: Q1 Earnings Snapshot AP - Thu May 4, 2023

Arbutus: Q1 Earnings Snapshot

ABUS : 3.79 (+2.71%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arbutus Biopharma Corporation - ABUS PR Newswire - Tue May 2, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arbutus Biopharma Corporation ("Arbutus" or the "Company") (NASDAQ: ABUS). Such...

ABUS : 3.79 (+2.71%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arbutus Biopharma Corporation - ABUS PR Newswire - Wed Apr 26, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arbutus Biopharma Corporation ("Arbutus" or the "Company") (NASDAQ: ABUS). Such...

ABUS : 3.79 (+2.71%)
Why Arbutus Biopharma Stock Is Sinking Today Motley Fool - Tue Apr 25, 2023

After a strong start to 2023, the virology-focused biopharma company has hit a regulatory speed bump.

ABUS : 3.79 (+2.71%)
Arbutus: Q3 Earnings Snapshot AP - Wed Nov 9, 2022

Arbutus: Q3 Earnings Snapshot

ABUS : 3.79 (+2.71%)

Barchart Exclusives

2 Penny Stocks Wall Street Expects to Soar Over 400% Barchart - 19 minutes ago
These two penny stock companies, while risky and volatile, have the potential to generate massive returns, according to Wall Street's price forecasts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot